These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25170604)

  • 1. Investigation of 3-D ordered materials with a high adsorption capacity for BSA and their potential application as an oral vaccine adjuvant.
    Zhang Q; Zhao Q; Zhang Y; Han N; Hu L; Zhang C; Jiang T; Wang S
    J Colloid Interface Sci; 2014 Nov; 434():113-21. PubMed ID: 25170604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of 3D ordered macroporous carbon with different polymer coatings and their application as an oral vaccine carrier.
    Zhao Q; Zhang Q; Yue Y; Huang J; Di D; Gao Y; Shao X; Wang S
    Int J Pharm; 2015 Jun; 487(1-2):234-41. PubMed ID: 25895720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.
    Wang T; Jiang H; Zhao Q; Wang S; Zou M; Cheng G
    Int J Pharm; 2012 Oct; 436(1-2):351-8. PubMed ID: 22721849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvant.
    Wang T; Zou M; Jiang H; Ji Z; Gao P; Cheng G
    Eur J Pharm Sci; 2011 Dec; 44(5):653-9. PubMed ID: 22064451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using procedure of emulsification-lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS).
    Wang N; Wang T; Zhang M; Chen R; Deng Y
    Int J Pharm; 2014 Jul; 468(1-2):39-49. PubMed ID: 24704308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
    Berner VK; Sura ME; Hunter KW
    Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon nanotube-protein carriers enhance size-dependent self-adjuvant antibody response to haptens.
    Parra J; Abad-Somovilla A; Mercader JV; Taton TA; Abad-Fuentes A
    J Control Release; 2013 Sep; 170(2):242-51. PubMed ID: 23735572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization.
    Singh P; Prabakaran D; Jain S; Mishra V; Jaganathan KS; Vyas SP
    Int J Pharm; 2004 Jul; 278(2):379-90. PubMed ID: 15196642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Conjugated Chitosan-Based Nanoparticles to Proteic Antigens Elicit Similar Humoral Immune Responses to Those Obtained with Alum.
    Izaguirre-Hernández IY; Mellado-Sánchez G; Mondragón-Vásquez K; Thomas-Dupont P; Sánchez-Vargas LA; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Vivanco-Cid H
    J Nanosci Nanotechnol; 2017 Jan; 17(1):846-52. PubMed ID: 29634187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.
    Carvalho LV; Ruiz Rde C; Scaramuzzi K; Marengo EB; Matos JR; Tambourgi DV; Fantini MC; Sant'Anna OA
    Vaccine; 2010 Nov; 28(50):7829-36. PubMed ID: 20937318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of self-assembled nanoceramic carrier construct(s) for vaccine delivery.
    Goyal AK; Khatri K; Mishra N; Mehta A; Vaidya B; Tiwari S; Paliwal R; Paliwal S; Vyas SP
    J Biomater Appl; 2009 Jul; 24(1):65-84. PubMed ID: 19386666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines.
    Salvador A; Igartua M; Hernández RM; Pedraz JL
    Vaccine; 2012 Jan; 30(3):589-96. PubMed ID: 22119926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannosylated niosomes as carrier adjuvant system for topical immunization.
    Jain S; Vyas SP
    J Pharm Pharmacol; 2005 Sep; 57(9):1177-84. PubMed ID: 16105238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.
    Gutierro I; Hernández RM; Igartua M; Gascón AR; Pedraz JL
    Vaccine; 2002 Nov; 21(1-2):67-77. PubMed ID: 12443664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Starch microparticles as an adjuvant in immunisation: effect of route of administration on the immune response in mice.
    Stertman L; Strindelius L; Sjöholm I
    Vaccine; 2004 Jul; 22(21-22):2863-72. PubMed ID: 15246622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immune response induced by BSA loaded in hydroxyethylstarch microparticles.
    Balasse E; Odot J; Gatouillat G; Andry MC; Madoulet C
    Int J Pharm; 2008 Apr; 353(1-2):131-8. PubMed ID: 18162346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhinoVax is an efficient adjuvant in oral immunisation of young chickens and cholera toxin B is an effective oral primer in subcutaneous immunisation with Freund's incomplete adjuvant.
    Mayo SL; Tufvesson M; Carlsson HE; Royo F; Gizurarson S; Hau J
    In Vivo; 2005; 19(2):375-82. PubMed ID: 15796200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the adjuvant effect of silver nanoparticles both in vitro and in vivo.
    Xu Y; Tang H; Liu JH; Wang H; Liu Y
    Toxicol Lett; 2013 May; 219(1):42-8. PubMed ID: 23454833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system.
    Wang N; Wang T; Zhang M; Chen R; Niu R; Deng Y
    Eur J Pharm Biopharm; 2014 Sep; 88(1):194-206. PubMed ID: 24769065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.